Retour à la liste des essais cliniquesThyroid cancer

INTERMEDIATE-01

Multicentric Phase III Trial Comparing Two Strategies in Intermediate-risk Differentiated Thyroid Cancer Patients: Systematic Radioiodine Administration (3.7 GBq I131 After rhTSH) Versus Decision of Radioiodine Treatment Guided by a Post-operative Work-up Based on Serum Tg Values and Diagnostic RAI Scintigraphy

Ouvert à Saint-Cloud depuis le : 29/01/2021
Public cible : Adult
Phase : Phase III

Description de l'essai

This trial is comparing two strategies in intermediate-risk differentiated thyroid cancer patients: Systematic radioiodine administration (3.7 GBq I131 after rhTSH) versus decision of radioiodine treatment guided by a post-operative work-up based on serum Tg values and diagnostic RAI scintigraphy

Url of the trial

Investigateur principal

CAPUCINE RICHARD

Médecin

Contacter